Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis

Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis Neelam Hassan, Neelam Hassan Department of Rheumatology, North Bristol NHS Trust, Bristol, UK https://orcid.org/0000-0001-7052-5708 Search for other works by this author on: Oxford Academic PubMed Google Scholar Emma Jane Davies, Emma Jane Davies Department of Rheumatology, North Bristol NHS Trust, Bristol, UK Search for other works by this author on: Oxford Academic PubMed Google Scholar Benjamin George Faber, Benjamin George Faber Department of Rheumatology, North Bristol NHS Trust, Bristol, UK Search for other works by this author on: Oxford Academic PubMed Google Scholar Harsha Gunawardena Harsha Gunawardena Department of Rheumatology, North Bristol NHS Trust, Bristol, UK Correspondence to: Harsha Gunawardena, Rheumatology Department, Gate 5 Brunel Building, North Bristol NHS Trust, Southmead Hospital, Bristol, BS10 5NB, UK. E-mail: harsha.gunawardena@nbt.nhs.uk Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, Volume 60, Issue 5, May 2021, Pages e156–e158, https://doi.org/10.1093/rheumatology/keaa698 Published: 22 November 2020 Article history Received: 07 July 2020 Revision received: 03 September 2020 Accepted: 24 September 2020 Published: 22 November 2020